Bank of America’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

Bank of America’s Portfolio LUXA Stock Details LUXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-324,746	Closed	-$3.25M	–	8740
2022 Q3	$3.25M	Hold	324,746	–	–	﹤0.01%	3803
2022 Q2	$3.21M	Sell	324,746 -56,996	-15%	-$563K	﹤0.01%	3856
2022 Q1	$3.76M	Buy	381,742 +184,100	+93%	+$1.81M	﹤0.01%	3931
2021 Q4	$1.94M	Hold	197,642	–	–	﹤0.01%	4595
2021 Q3	$1.94M	Buy	197,642 +56,996	+41%	+$561K	﹤0.01%	4481
2021 Q2	$1.39M	Buy	+140,646	New	+$1.42M	﹤0.01%	4627

Bank of America's LUXA Position: Q4 2022 in Review

Bank of America sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q4 2022, closing a stake of 324,746 shares — an estimated $3.25M sold.

Bank of America first reported a position in LUXA in Q2 2021 and held it in 6 quarters. The position peaked at $3.76M in Q1 2022. 0 funds tracked by Wall St. Rank hold LUXA as of Q4 2022.

Bank of America reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Bank of America sold 324,746 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $3.25M.
Bank of America first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q2 2021 and held it in 6 quarters.
Bank of America's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $3.76M in Q1 2022.
0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Bank of America's 13F filing for Q4 2022, filed 10 Feb 2023.